86 related articles for article (PubMed ID: 2269442)
1. High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coli.
Sisk WP; Davis GL; Kingsley D; Chiu AT; Reilly TM
Gene; 1990 Dec; 96(2):305-9. PubMed ID: 2269442
[TBL] [Abstract][Full Text] [Related]
2. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
3. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
[TBL] [Abstract][Full Text] [Related]
4. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.
Pannekoek H; Veerman H; Lambers H; Diergaarde P; Verweij CL; van Zonneveld AJ; van Mourik JA
EMBO J; 1986 Oct; 5(10):2539-44. PubMed ID: 2430793
[TBL] [Abstract][Full Text] [Related]
5. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.
Franke AE; Danley DE; Kaczmarek FS; Hawrylik SJ; Gerard RD; Lee SE; Geoghegan KF
Biochim Biophys Acta; 1990 Jan; 1037(1):16-23. PubMed ID: 2403813
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of human plasminogen activator inhibitor type I expressed in Saccharomyces cerevisiae.
Gardell SJ; Hare TR; Han JH; Markus HZ; Keech BJ; Carty CE; Ellis RW; Schultz LD
Arch Biochem Biophys; 1990 May; 278(2):467-74. PubMed ID: 2183723
[TBL] [Abstract][Full Text] [Related]
8. cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell.
Wun TC; Kretzmer KK
FEBS Lett; 1987 Jan; 210(1):11-6. PubMed ID: 3026837
[TBL] [Abstract][Full Text] [Related]
9. Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
Ny T; Sawdey M; Lawrence D; Millan JL; Loskutoff DJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6776-80. PubMed ID: 3092219
[TBL] [Abstract][Full Text] [Related]
10. Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
Lawrence DA; Strandberg L; Ericson J; Ny T
J Biol Chem; 1990 Nov; 265(33):20293-301. PubMed ID: 1700786
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of active human plasminogen activator inhibitor type 1 (PAI-1) in E. coli.
Zhou A; Pei Y; Wu H; Dong X; Xu X
Biochem Mol Biol Int; 1996 May; 39(2):235-42. PubMed ID: 8799449
[TBL] [Abstract][Full Text] [Related]
12. cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
Ye RD; Wun TC; Sadler JE
J Biol Chem; 1987 Mar; 262(8):3718-25. PubMed ID: 3029122
[TBL] [Abstract][Full Text] [Related]
13. Functional display of human plasminogen-activator inhibitor 1 (PAI-1) on phages: novel perspectives for structure-function analysis by error-prone DNA synthesis.
Pannekoek H; van Meijer M; Schleef RR; Loskutoff DJ; Barbas CF
Gene; 1993 Jun; 128(1):135-40. PubMed ID: 8508955
[TBL] [Abstract][Full Text] [Related]
14. Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae.
Steven J; Cottingham IR; Berry SJ; Chinery SA; Goodey AR; Courtney M; Ballance DJ
Eur J Biochem; 1991 Mar; 196(2):431-8. PubMed ID: 1901039
[TBL] [Abstract][Full Text] [Related]
15. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli.
Zhou A; Jiang X; Dou F; Zhu D; Xu X
J Biochem; 1997 May; 121(5):930-4. PubMed ID: 9192735
[TBL] [Abstract][Full Text] [Related]
16. Saturation mutagenesis of the plasminogen activator inhibitor-1 reactive center.
Sherman PM; Lawrence DA; Yang AY; Vandenberg ET; Paielli D; Olson ST; Shore JD; Ginsburg D
J Biol Chem; 1992 Apr; 267(11):7588-95. PubMed ID: 1559996
[TBL] [Abstract][Full Text] [Related]
17. Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.
Pöllänen J; Vaheri A; Tapiovaara H; Riley E; Bertram K; Woodrow G; Stephens RW
Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2230-4. PubMed ID: 2138329
[TBL] [Abstract][Full Text] [Related]
18. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1.
Zeheb R; Gelehrter TD
Gene; 1988 Dec; 73(2):459-68. PubMed ID: 3149611
[TBL] [Abstract][Full Text] [Related]
19. cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.
Ginsburg D; Zeheb R; Yang AY; Rafferty UM; Andreasen PA; Nielsen L; Dano K; Lebo RV; Gelehrter TD
J Clin Invest; 1986 Dec; 78(6):1673-80. PubMed ID: 3097076
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and secretion of a fibrinolytically active tissue-type plasminogen activator variant in Escherichia coli.
Waldenström M; Holmgren E; Attersand A; Kalderén C; Löwenadler B; Rådén B; Hansson L; Pohl G
Gene; 1991 Mar; 99(2):243-8. PubMed ID: 1902433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
